China Has Been Using a Covid-19 Vaccine Since July, Admits Health Official

• A top Chinese health official has recently confirmed that the country has been using an experimental coronavirus vaccine since July.
• According to Zheng Zhongwei, the said vaccine has mostly been given to frontline workers including medical professionals and border inspectors.
• The vaccine has undergone Phase 3 human trials in several countries.

A senior health official from China has recently confirmed that the country already has an experimental vaccine against coronavirus – and they have been using it since July. So far, medical frontliners and border workers have received doses of the drug.

In an August 22 interview with CCTV-2’s “Dialogue,” Science and Technology Development Center of the National Health Commission director Zheng Zhongwei revealed that a COVID-19 vaccine has received approval as early as July 22.

The said vaccine, which has been developed by Sinopharm’s China National Biotec Group Company (CNBG), has earlier undergone its Phase 3 trials in Argentina, Morocco, Peru and in the United Arab Emirates, said a CNN report. .

According to Zheng:

“There are clear provisions in Article 20 of our country’s vaccine law. When a major public health incident occurs, the National Health Commission submits an application for emergency use of vaccines, and the State Food and Drug Administration organizes experts to evaluate and agree to the NHC for emergency use of vaccines within a certain scale and within a certain limited time.”

Zheng, who heads the Joint Prevention and Control Mechanism of the State Council’s
vaccine research and development group, also explained further that it is crucial to “build up an immune barrier for medical staff.”

Once that is done successfully, then “personnel involved in basic operation of the city, such as those in the farmers market, transportation, and in some service industries” could then qualify for the vaccine as well.

As of this writing, China has the most number of coronavirus vaccine candidates in human trials compared with any other country across the world.